Axios Alerts: Moderna's COVID vaccine safe and highly effective in adolescents, study shows

Alerts   Axios    Moderna's COVID vaccine safe and highly effective in adolescents, study shows Why it matters: The company plans to submit its data to global regulators in early June, paving the way for an emergency use authorization for 12- to 17-year-olds.   Download the Axios App Follow Axios on Social Media Contact Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201   You received this email because you signed up for news alerts from Axios. Change your preferences or unsubscribe here.